Inogen, Inc (NASDAQ:INGN) is reporting second quarter financial results on Tuesday 4th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, INGN is expected to report 2Q20 loss of $ 0.08 per share from revenue of $ 79.96 million.
For the full year, analysts anticipate top line of $ 338.83 million, while looking forward to loss of $ 0.13 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 385.00 million ~ $ 400.00 million
Click Here For More Historical Outlooks Of Inogen, Inc
Previous Quarter Performance
Inogen, Inc disclosed loss for the first quarter of $ 0.07 per share, from the revenue of $ 88.49 million. The quarterly revenues down 1.90 percent compared with the same quarter last year. Wall street analysts are predicting, INGN to report 1Q20 loss of $ 0.10 per share from revenue of $ 82.33 million. The bottom line results beat street analysts by $ 0.03 or 30.00 percent, at the same time, top line results outshined analysts by $ 6.16 million or 7.48 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Inogen, Inc
Stock Performance
According to the previous trading day, closing price of INGN was $ 29.82, representing a 1.84 % increase from the 52 week low of $ 29.28 and a 61.22 % decrease over the 52 week high of $ 76.89.
The company has a market capital of $ 657.46 million and is part of the Healthcare sector and Medical Devices industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”INGN” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Recent Analyst recommendations
- On 11th June 2020, downgraded by William Blair to Market Perform from Outperform rating.
Conference Call
Inogen, Inc will be hosting a conference call at 4:30 PM eastern time on 4th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.inogen.com
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.
